Pediatricians must disclose adverse events and medical errors to children and their families, according to an updated policy ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of myopia in children. Considered a common ...